Table 1 Baseline characteristics of the included patient cohort
N (%) | Overall cohort | Lower | Intermediate | Higher | P value |
|---|---|---|---|---|---|
N = 650 | 215 (100.0) | 220 (100.0) | 215 (100.0) | ||
Demographic characteristics | |||||
Gender, male, N (%) | 467 (71.8) | 145 (67.8) | 160 (72.7) | 161 (74.9) | 0.243 |
Age, years | 66.00 [58.00, 73.00] | 65.00 [57.00, 71.00] | 66.50 [58.75, 72.25] | 66.00 [59.00, 73.00] | 0.289 |
Weight, kg | 86.00 [78.00, 96.00] | 85.00 [75.00, 94.60] | 86.00 [79.00, 96.00] | 88.40 [80.00, 98.30] | 0.023 |
Height, cm | 175.00 [169.00, 182.00] | 175.00 [168.00, 180.00] | 175.00 [169.00, 182.00] | 176.00 [170.00, 182.50] | 0.341 |
Body mass index, kg/m2 | 27.78 [25.72, 30.86] | 27.44 [25.06, 30.48] | 27.99 [25.71, 30.47] | 28.34 [26.02, 31.62] | 0.081 |
Comorbid conditions (%) | |||||
Comorbid. None | 156 (24) | 42 (19.6) | 55 (25.0) | 59 (27.4) | 0.153 |
Hypertension | 209 (32.2) | 83 (38.8) | 58 (26.4) | 67 (31.2) | 0.02 |
Heart failure | 29 (4.5) | 11 (5.1) | 7 (3.2) | 11 (5.1) | 0.524 |
Diabetes mellitus | 141 (21.7) | 54 (25.2) | 34 (15.5) | 53 (24.7) | 0.021 |
Chronic kidney disease | 25 (3.8) | 10 (4.7) | 5 (2.3) | 10 (4.7) | 0.326 |
Liver cirrhosis | 2 (0.3) | 0 (0.0) | 1 (0.5) | 1 (0.5) | 0.61 |
COPD | 50 (7.7) | 15 (7.0) | 18 (8.2) | 17 (7.9) | 0.892 |
Hematological malignancy | 10 (1.5) | 3 (1.4) | 4 (1.8) | 3 (1.4) | 0.919 |
Solid tumor malignancy | 18 (2.8) | 7 (3.3) | 8 (3.6) | 3 (1.4) | 0.314 |
Neuromuscular disease | 4 (0.6) | 1 (0.5) | 1 (0.5) | 2 (0.9) | 0.772 |
Immunosuppression use | 10 (3.1) | 7 (3.3) | 6 (2.7) | 7 (3.3) | 0.932 |
Other comorbidities | 315 (48.5) | 108 (50.5) | 108 (49.1) | 99 (46.0) | 0.644 |
Unknown comorbidities | 2 (0.3) | 1 (0.5) | 1 (0.5) | 0 (0.0) | 0.608 |
Creatinine (µmol/L) | 76.00 [61.00, 95.00] | 74.00 [61.00, 93.00] | 73.00 [57.50, 93.50] | 79.00 [64.00, 103.25] | 0.079 |